Literature DB >> 26424418

Do common genotypes of FK506 binding protein 5 (FKBP5) moderate the effects of childhood maltreatment on cognition in schizophrenia and healthy controls?

Melissa J Green1, Alessandra Raudino2, Murray J Cairns3, Jingqin Wu4, Paul A Tooney3, Rodney J Scott5, Vaughan J Carr2.   

Abstract

Common variants of the FK506 binding protein 5 (FKBP5) gene are implicated in psychotic and other disorders, via their role in regulating glucocorticoid receptor (GR) receptor sensitivity and effects on the broader function of the HPA system in response to stress. In this study, the effects of four FKBP5 polymorphisms (rs1360780, rs9470080, rs4713902, rs9394309) on IQ and eight other cognitive domains were examined in the context of exposure to childhood maltreatment in 444 cases with schizophrenia and 292 healthy controls (from a total sample of 617 cases and 659 controls obtained from the Australian Schizophrenia Research Bank; ASRB). Participants subjected to any kind of maltreatment (including physical, emotional, or sexual abuse or physical or emotional neglect) in childhood were classified as 'exposed'; cognitive functioning was measured with Repeatable Battery for the Assessment of Neuropsychological Status, the Controlled Oral Word Association Test, and IQ was estimated with the Weschler Test of Adult Reading. Hierarchical regressions were used to test the main effects of genotype and childhood maltreatment, and their additive interactive effects, on cognitive function. For rs1360870, there were significant main effects of genotype and childhood maltreatment, and a significant interaction of genotype with childhood trauma affecting attention in both schizophrenia and healthy participants (C-homozygotes in both groups showed worse attention in the context of maltreatment); in SZ, this SNP also affected global neuropsychological function regardless of exposure to childhood trauma, with T-homozygotes showing worse cognition than other genotypes. The mechanisms of trauma-dependent effects of FKBP5 following early life trauma deserve further exploration in healthy and psychotic samples, in the context of epigenetic effects and perhaps epistasis with other genes. Study of these processes may be particularly informative in subgroups exposed to various other forms of early life adversity (i.e., birth complications, immigration).
Copyright © 2015. Published by Elsevier Ltd.

Entities:  

Keywords:  Childhood trauma; Cognitive impairment; FKBP5; GxE; Psychosis

Mesh:

Substances:

Year:  2015        PMID: 26424418     DOI: 10.1016/j.jpsychires.2015.07.019

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  6 in total

1.  The emerging role of the FKBP5 gene polymorphisms in vulnerability-stress model of schizophrenia: further evidence from a Serbian population.

Authors:  Marina Mihaljevic; Katarina Zeljic; Ivan Soldatovic; Sanja Andric; Tijana Mirjanic; Alexander Richards; Kiran Mantripragada; Tatjana Pekmezovic; Ivana Novakovic; Nadja P Maric
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-08-23       Impact factor: 5.270

2.  A BRIEF INTRODUCTION TO THE NEUROGENETICS OF COGNITION-EMOTION INTERACTIONS.

Authors:  Matthew A Scult; Ahmad R Hariri
Journal:  Curr Opin Behav Sci       Date:  2017-10-15

3.  Childhood Trauma and Neurocognition in Adults With Psychotic Disorders: A Systematic Review and Meta-analysis.

Authors:  Teresa Vargas; Phoebe H Lam; Matilda Azis; K Juston Osborne; Amy Lieberman; Vijay A Mittal
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

4.  Interactions Between Variation in Candidate Genes and Environmental Factors in the Etiology of Schizophrenia and Bipolar Disorder: a Systematic Review.

Authors:  Błażej Misiak; Filip Stramecki; Łukasz Gawęda; Katarzyna Prochwicz; Maria M Sąsiadek; Ahmed A Moustafa; Dorota Frydecka
Journal:  Mol Neurobiol       Date:  2017-08-18       Impact factor: 5.590

Review 5.  The Impact of Childhood Trauma on Developing Bipolar Disorder: Current Understanding and Ensuring Continued Progress.

Authors:  Yann Quidé; Leonardo Tozzi; Mark Corcoran; Dara M Cannon; Maria R Dauvermann
Journal:  Neuropsychiatr Dis Treat       Date:  2020-12-14       Impact factor: 2.570

6.  Adverse Childhood Experiences and Methylation of the FKBP5 Gene in Patients with Psychotic Disorders.

Authors:  Błażej Misiak; Paweł Karpiński; Elżbieta Szmida; Tomasz Grąźlewski; Marcin Jabłoński; Katarzyna Cyranka; Joanna Rymaszewska; Patryk Piotrowski; Kamila Kotowicz; Dorota Frydecka
Journal:  J Clin Med       Date:  2020-11-24       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.